Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-24-034957
Filing Date
2024-11-13
Accepted
2024-11-13 17:01:21
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 clnn20241008_s3.htm S-3 342016
2 EXHIBIT 5.1 ex_730915.htm EX-5.1 13343
3 EXHIBIT 23.2 ex_730916.htm EX-23.2 2434
4 FILING FEE TABLE ex_730928.htm EX-FILING FEES 18170
5 clenelogo11percent.jpg GRAPHIC 10252
6 hklogo35px.jpg GRAPHIC 8086
7 pipelineoct202423pct.jpg GRAPHIC 100584
  Complete submission text file 0001437749-24-034957.txt   541224
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283204 | Film No.: 241455449
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)